Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jane, Woolcock"'
Autor:
Joop S.E. Laven, Kathleen M. Hoeger, Nigel K. Stepto, Bulent O. Yildiz, Kate Marsh, Ricardo Azziz, Angelica Lindén Hirschberg, Adam H. Balen, Juha S. Tapanainen, Jane Speight, Roger Hart, Eszter Vanky, Angela Wan, Shakila Thangaratinam, Bart C.J.M. Fauser, Rong Li, Luigi Devoto, Lisa J. Moran, Leah Brennan, Edgar Mocanu, Duru Shah, Jie Qiao, Michael F. Costello, Elisabet Stener-Victorin, Darren Mansfield, Mala Thondan, Rachel Hawkes, Anju E. Joham, Jane Woolcock, Marla E. Lujan, Sasha Ottey, Rhonda Garad, Samantha K. Hutchison, Poli Mara Spritzer, Helena J. Teede, Raymond J. Rodgers, Eliza C. Tassone, Estifanos Baye, Daniela Romualdi, Leanne M. Redman, Richard S. Legro, Chii Ruey Tzeng, Veryan McAllister, Jaideep Malhotra, Stephen Franks, Frank J.M. Broekmans, Ben W.J. Mol, Preeti Dabadghao, Cheryce L. Harrison, Sharon E. Oberfield, Robert J. Norman, Terhi Piltonen, Ernest Hung Yu Ng, Selma F. Witchel, Luk Rombauts, Maria G. Vogiatzi, Louise Johnson, Marianne Andersen, Cailin Jordan, Melanie Gibson-Helm, Chandrika N Wijeyaratne, Zephne M van der Spuy, Linda Downes, Femke P Hohmann, Anuja Dokras, Jayashri Kulkarni, Alexia S Peña, Marie Misso, Didier Dewailly, Jacqueline Boyle
Publikováno v:
Human Reproduction, 33(9), 1602. Oxford University Press
Fertility & Sterility, 110(3), 364-379. Elsevier Inc.
Fertility and sterility
Clinical Endocrinology, 89(3), 251. Wiley-Blackwell
International PCOS Network & Skovsager Andersen, M 2018, ' Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ', Human reproduction (Oxford, England), vol. 33, no. 9, pp. 1602-1618 . https://doi.org/10.1093/humrep/dey256
Clinical Endocrinology, 89(3), 251-268. Wiley-Blackwell Publishing Ltd
Human Reproduction, 33(9), 1602-1618. Oxford University Press
Andersen, M & International PCOS Network 2018, ' Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ', Clinical Endocrinology, vol. 89, no. 3, pp. 251-268 . https://doi.org/10.1111/cen.13795
Human Reproduction (Oxford, England)
Fertility & Sterility, 110(3), 364-379. Elsevier Inc.
Fertility and sterility
Clinical Endocrinology, 89(3), 251. Wiley-Blackwell
International PCOS Network & Skovsager Andersen, M 2018, ' Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ', Human reproduction (Oxford, England), vol. 33, no. 9, pp. 1602-1618 . https://doi.org/10.1093/humrep/dey256
Clinical Endocrinology, 89(3), 251-268. Wiley-Blackwell Publishing Ltd
Human Reproduction, 33(9), 1602-1618. Oxford University Press
Andersen, M & International PCOS Network 2018, ' Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ', Clinical Endocrinology, vol. 89, no. 3, pp. 251-268 . https://doi.org/10.1111/cen.13795
Human Reproduction (Oxford, England)
STUDY QUESTION: What is the recommended assessment and management of women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise and consumer preference?SUMMARY ANSWER: International evidence-based guidelines
Autor:
Jasmin Sekhon, Shawn Tan, Jane Woolcock, Glen Lo, Melody Menezes, Anthony Murphy, Emmeline Lee, Simon Meagher, Jayshree Ramkrishnan
Publikováno v:
The AustralianNew Zealand journal of obstetricsgynaecologyReferences. 60(6)
Background Lipiodol tubal flushing is offered to select subfertile women primarily to confirm tubal patency and to increase pregnancy rates. Aims To investigate the safety of hystero-salpingo contrast sonography (HyCoSy) using Lipiodol flush (through
Autor:
Jane, Woolcock, Rosalie, Grivell
Publikováno v:
Australian family physician. 43(7)
Noninvasive prenatal testing (NIPT) has marked a revolution in aneuploidy screening because it allows a simple maternal blood test to detect Down syndrome in a fetus with a very high level of accuracy (at least 99.5% with a false-positive rate of 0.2